Verywell Health's content is for informational and educational purposes only. Our website is not intended to be a substitute ...

In late August, in time for the fall season, the Food and Drug Administration authorized and approved updated COVID-19 ...

Researchers at Kumamoto University have made a significant breakthrough in the fight against COVID-19 with the development of ...

Over the last few years, the SARS-CoV-2 virus, responsible for COVID-19, has undergone significant changes, evolving from the ...

S eniors and people who are immunocompromised should get not just one but two COVID-19 shots this respiratory virus season.

COVID-19 survivors may develop autoimmune conditions long-term, with risks varying by severity and vaccination status, ...

A new retrospective cohort study conducted in Dubai shows that the antiviral nirmatrelvir plus ritonavir, sold as Paxlovid, ...

The 2024–2025 COVID-19 vaccines are recommended for everyone aged 6 months and older in the US to target the currently circulating SARS-CoV-2 strains, JN.1 and KP.2.

The investigators explained that AMN, a rare disease, is characterized by dark reddish, wedge-shaped macular lesions. 2 ...

COVID-19 Contagiousness Over Time How long you are ... antibodies you have from previous infection or vaccination. The Omicron variant has 26 spike protein mutations, allowing for more subvariants ...

The new Omicron variant is expected to infect 60 per cent of people in China in the coming three months. Symptoms of COVID-19 can range from mild to severe, and can include fever, cough ...

In August, the Food and Drug Administration authorized updated vaccines against COVID-19. Here's what to know about the three vaccines available in the U.S.